Mumbai,December 24 dmanewsdesk: India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc (NYSE: MDT), today announced the launch of EEA™ Circular Stapler with Tri-Staple™ Technology – the first 3-row Circular Stapler with varied height staples. The new Tri-Staple™ Technology comprises a sloped cartridge face that delivers less stress on tissue. It also offers consistent performance over a broad range of tissue thickness and allows for greater perfusion into the staple line 1,2,3,4,5,‡‡,††.
The EEA™ circular stapler with Tri-Staple™ technology is indicated for use in colorectal procedures, where safer anastomosis (surgical connection between two loops of the intestine) is required to avoid any leaks. The device has three rows of varied height staples to deliver 30 percent more security to the staple line and requires 60% lesser firing force in the operating room as compared to current devices6. Moreover, the device comes with improved audible and tactile feedback that enables clinicians with better decision-making in the operating room‡,†,7. Additionally, the tilt-top mechanism on the device facilitates easy removal during colorectal surgeries. The promise of higher security and greater perfusion at the staple line is expected to deliver better clinical outcomes for patients.
“Meaningful innovations are not only limited to a new product. They can also offer a novel, even disruptive, way of delivering an existing treatment to empower physicians to treat their patients effectively. The Tri-Staple™ EEA™ circular stapler is the latest addition to Medtronic’s Tri-staple technology portfolio. Medtronic has been at the forefront of innovation and we have evolved our products through continuous technological innovation in all aspects of their design, materials & delivery mechanism.” said Madan Krishnan, Vice President & Managing Director, India Medtronic Pvt Ltd.
The EEA™ circular stapler with Tri-Staple™ technology is designed to work in harmony with the natural properties of the tissue before, during and after stapling. With its stepped cartridge face, the Tri-Staple™ technology delivers graduated compression that optimizes interaction between the tissue and stapler.
Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
† As compared to two-row circular staplers.
‡ 16 out of 19 surgeons surveyed agreed.
§ Based on the addition of a third row of staples in the EEA™ circular stapler with Tri-Staple™ technology, as compared to predicate two-row device designs.
Ω Refers to the healing period (generally through day 28) that was evaluated in multiple preclinical (canine) survival studies designed to assess device safety and efficacy.
†† Preclinical results may not correlate with clinical performance in humans.
‡‡ Finite element analysis (FEA) was used to determine the strain profiles of three circular staplers during clamp-up. The EEA™ circular stapler with Tri-Staple™ technology demonstrated a graduated compression profile upon clamping.
1. Based on internal test report #PCG-007, Media absorbency under clamped conditions. Aug. 6, 2012.
2. Based on internal test report #PCG-30, Comparison of circular staplers: tissue compression profiles as determine by 2-D static axisymmetric finite element analysis (FEA). Aug. 2, 2018.
3. Based on internal test report #RE00069039, EEA™ circular stapler with Tri-Staple™ technology design verification report. Dec. 2, 2014.
4. Based on internal test report #2128-053, Ethicon benchmark testing — Signia™ circular reload. June 17, 2014.
5. Based on extrapolation of perfusion studies performed for Endo GIA™ with Tri-Staple™ technology: internal test report #2128-002-
2, Final analysis of staple line vascularity using MicroCT. April 27, 2015.
6. Based on internal test report #RE00183973, Firing force and audible feedback test report. May 2019.
7. Based on internal test report #RE00073061, Tulip formative evaluation summary. Nov. 25,2016.
Source: Business Wire India